6-[n-(3-methoxy-phenyl)-3-(morpholin-4-ylmethyl)-2h-thieno[3,2-e]-1,2-thiazine-1,1,-dioxide]-sulfonamide (INL) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.075
Number of clusters 31
Number of clusters representing 95% 9
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.3477
ΔGstrain (kcal/mol) 0.4096
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 2051 0 2.0967
2 1598 0.1477 0.9731
3 1483 0.1920 2.2352
4 1027 0.4096 0.7034
5 952 0.4545 0.9388
6 801 0.5567 1.7549
7 654 0.6768 2.0728
8 651 0.6795 2.1416
9 517 0.8160 1.7323
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)